logo
calendar11 Dekabr 2021
view28
Main language:Russian

MICROALBUMINURIA AS A DIAGNOSTIC MARKER OF TUBULOINTERSTITIAL KIDNEY DAMAGE IN CHILDREN WITH SECONDARY OXALATE NEPHROPATHY

Field of Science:
pdf

61b98c93b4ad2.pdf

PDF

RE-HEALTH

RE-HEALTH

Publish Articlesee more

ARTICLE ANNOTATION

quote
In recent decades, the problem of nephrolithiasis has become more and more urgent among children and adults. It has been established that nephrolithiasis in almost 75 - 80% of cases consists of calcium salts, namely calcium oxalate (CaOx), which enters the body through food, but the bulk is formed endogenously. It has been determined that hyperoxaluria is common in diabetic and obese patients, contributing to an increased risk of stone formation. Moreover, untimely detected hyperoxaluria in childhood can lead to transformation into nephrolithiasis in adults.

AUTHORS

A.Sharipov

Ташкентский педиатрический медицинский институт

M.Ortiqova

Ташкентский педиатрический медицинский институт

M.Axmatali

Ташкентский педиатрический медицинский институт

Tags

# дети# children# болалар# microalbuminuria# микроальбуминурия# диагностический маркер# тубулоинтерстициальный нефрит# вторичная оксалатная нефропатия# гипероксалурия# иккиламчи оксалатли нефропатия# оксалурия# diagnostic marker# secondary oxalate nephropathy# hyperoxaluria

OTHER ARTICLES IN THIS JOURNAL

Rate Article

0
0 ratings
5
4
3
2
1

Article Identifiers

ROI:

https://eroi.uz/11.0082/A1221-0040

DOI:

Not Available

References

1. Garg JP, Bakris GL. Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease. Vasc Med. 2002;7(1):35‐43. [PubMed] [Google Scholar]

2. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity‐onset diabetes. N Engl J Med. 1984;310:356‐360. [PubMed] [Google Scholar]

3. Mojahedi MJ, Bonakdaran S, Hami M, Sheikhian MR, Shakeri MT, Aiatollahi H. Elevated serum c‐reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus. Iran J Kidney Dis. 2009;3(1):12‐16. [PubMed] [Google Scholar]

4. Tejani A, Phadke K, Adamson O, Nicastri A, Chen CK, Sen D. Renal lesions in sickle cell nephropathy in children. Nephron. 1985;39:352–355. doi: 10.1159/000183404. [PubMed] [CrossRef] [Google Scholar]

5. Eke CB, Okafor HV, Ibe BC. Prevalence and correlates of microalbuminuria in children with sickle cell anaemia: experience in a tertiary health facility in Enugu, Nigeria. Int J Nephrol. 2012;10:1152–1162. [PMC free article] [PubMed] [Google Scholar]

6. Keane WF, Eknoyan G. Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. Am J Kidney Dis. 1999;33: 1004–1010. [PubMed] [Google Scholar]

7. Rademacher ER, Sinaiko AR. Albuminuria in children. Curr Opin Nephrol Hypertens. 2009;18: 246–251. doi: 10.1097/MNH.0b013e3283294b98 [PubMed] [Google Scholar]

8. Radhakishun NN, van Vliet M, von Rosenstiel IA, Beijnen JH, Diamant M. Limited value of routine microalbuminuria assessment in multi-ethnic obese children. Pediatr Nephrol. 2013;28: 1145–1149. doi: 10.1007/s00467-013-2451- 6 [PubMed] [Google Scholar]

9. Lurbe E, Torro MI, Alvarez J, Aguilar F, Fernandez-Formoso JA, Redon J. Prevalence and factors related to urinary albumin excretion in obese youths. J Hypertens. 2013;31: 2230–2236; discussion 2236. doi: 10.1097/HJH.0b013e328364bcbf [PubMed] [Google Scholar]

10. Ding W, Mak RH. Early markers of obesity-related renal injury in childhood. Pediatr Nephrol. 2015;30: 1 –4. doi: 10.1007/s00467-014-2976-3 [PubMed] [Google Scholar]

11. Goknar N, Oktem F, Ozgen IT, Torun E, Kucukkoc M, Demir AD, et al. Determination of early urinary renal injury markers in obese children. Pediatr Nephrol. 2015;30: 139–144. doi: 10.1007/s00467-014-2829-0 [PubMed] [Google Scholar]

12. Gerstein HC, Mann JF, Yi Q. Albuminuria and risk of cardiovascular events, death and heart failure in diabetic and nondiabetic individuals. JAMA. 2001;286:421–426. doi: 10.1001/jama.286.4.421. [PubMed] [CrossRef] [Google Scholar]

13. Pinto-Sietsma SJ, Janssen WM, Hillege HL. Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population. J Am Soc Nephrol. 2000;11:1882–1888. [PubMed] [Google Scholar]

14. Pedrinelli R, Dell’Omo G, Di Bello V. Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension. J Hum Hypertens. 2002;16:79–89. doi: 10.1038/sj.jhh.1001316. [PubMed] [CrossRef] [Google Scholar]

15. Hillege HL, Fidler V, Diercks GF. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002;106:1777–1782. doi: 10.1161/01.CIR.0000031732.78052.81. [PubMed] [CrossRef] [Google Scholar]

16. Solbu MD, Kronborg J, Jenssen TG. Albuminuria, metabolic syndrome and the risk of mortality and cardiovascular events. Atherosclerosis. 2009;204:503–508. doi: 10.1016/j.atherosclerosis.2008.11.002. [PubMed] [CrossRef] [Google Scholar]

17. Kshirsagar AV, Bomback AS, Bang H. Association of C-reactive protein and microalbuminuria (from the National Health and Nutrition Examination Surveys, 1999 to 2004) Am J Cardiol. 2008;101:401–406. doi: 10.1016/j.amjcard.2007.08.041. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

18. Nakamura M, Onoda T, Itai K. Association between serum C-reactive protein levels and microalbuminuria: a population-based cross-sectional study in northern Iwate, Japan. Intern Med. 2004;43:919–925. doi: 10.2169/internalmedicine.43.919. [PubMed] [CrossRef] [Google Scholar]

19. Fox ER, Benjamin EJ, Sarpong DF. The relation of C-reactive protein to chronic kidney disease in African Americans:the Jackson Heart Study. BMC Nephrol. 2010;11:1. doi: 10.1186/1471 -2369-11-1. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

20. Festa A, D'Agostino RD, Howard G. Inflammation and microalbuminuria in nondiabetic and type 2diabetic subjects: The Insulin Resistance Atherosclerosis Study. Kidney Int. 2000;58:1703–1710. doi: 10.1046/j.1523- 1755.2000.00331.x. [PubMed] [CrossRef] [Google Scholar]

21. Liping Jiang, Wen Huang, Yuanbo Liang, Fenghua Wang, Xinrong Duan, Xiaohui Yang, Jiangping Wen, Ningli Wang. Metabolic syndrome, C-reactive protein and microalbuminuria in a rural Chinese population: a cross-sectional study. BMC Nephrol. 2013; 14: 118. doi: 10.1186/1471-2369-14-118PubMed

22. Патогенетические механизмы формирования нефропатии при сахарном диабете 1 типа Л. В. Куценко, И. В. Зорин, А. А. Вялкова Для цитирования: Лечащий врач № 6/2018; Номера страниц в выпуске: 58-61

23. Дисметаболические нефропатии в практике педиатра/ А. В. Малкоч, Е. Г. Куликова, Ю. Б. Юрасова Для цитирования: Лечащий врач № 1/2019; Номера страниц в выпуске: 34-39

24. Зорин, И. В. Клинико-анамнестическая характеристика детей с пузырно-мочеточниковым рефлюксом и рефлюкс-нефропатией / И. В Зорин // Нефрология. – 2014. – Том 18. – №3. – С. 77–83.

25. Значение нарушений внутрипочечной гемодинамики в формировании тубу-лоинтерстициального поражения почек у детей. / И. В Зорин [и др.] // Лечащий Врач. – 2016. – №. 1. – С. 63–68.